EMERYVILLE, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the first quarter ended March 31, 2016 after the market close, and will host a corporate update conference call and webcast on Tuesday, May 10th, at 4:30 PM Eastern Time.
| Tuesday, May 10th @ 4:30 PM Eastern Time/1:30 PM Pacific Time | |
| Toll Free: | 888-576-4398 |
| International: | 719-457-2727 |
| Conference ID: | 6099104 |
| Webcast: | http://public.viavid.com/index.php?id=119074 |
| Replays, available through May 24: | |
| Domestic: | 877-870-5176 |
| International: | 858-384-5517 |
| Replay PIN: | 6099104 |
About Zogenix
Zogenix, Inc. (NASDAQ:ZGNX) is an innovative pharmaceutical company committed to providing unique therapeutic solutions for people living with rare and burdensome disease conditions. Our focused strategy centers on advancing late-stage, high-value products for CNS disorders that will significantly improve outcomes for patients and physicians.
For more information, visit www.zogenix.com.